Prescription medicine
Multiple vitamins Brand names: Infuvite
Multiple vitamins (Infuvite) is a prescription medicine. No generic is listed in FDA's NDC Directory.
- No generic listed
Check it at the source: the multiple vitamins FDA label on DailyMed (effective November 20, 2024); every multiple vitamins label on DailyMed.
Highlights of the record
FDA label of November 20, 2024; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026
Used for
From the label: indications and usageINFUVITE PEDIATRIC is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition.
Forms and strengths
Kit.
On the market
- Generic approvals
- No generic approved
- Labelers listed (NDC)
- 1 of which 0 under generic applications, 1 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- Not in the survey
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- 2 since 2024 0 Class I among all firms' recalls; latest April 25, 2025
- FAERS reports
- 156 through July 30, 2026
What is multiple vitamins used for?
From the label: indications and usageINFUVITE PEDIATRIC is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. The physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. INFUVITE PEDIATRIC is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition
Source: FDA drug label (Infuvite Pediatric), Sandoz Inc, effective November 20, 2024 (SPL set 6d06546e-8b0a-4490-82d9-397bd902a044), via openFDA; the full label on DailyMed
Is there a generic for multiple vitamins (Infuvite)?
No generic multiple vitamins is approved (Drugs@FDA, October 8, 2026).
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
Has multiple vitamins been recalled?
The FDA's Enforcement Report lists 2 recalls naming multiple vitamins since 2024: 0 Class I (the most serious), 2 Class II, 0 Class III; 1 still ongoing. A recall names products and lots, not every product of the medicine.
| Started | Class | Company | Reason |
|---|---|---|---|
| April 25, 2025 | Class II | Mckesson Medical-Surgical Inc. Corporate Office | Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery … |
| February 7, 2024 | Class II | Mckesson Medical-Surgical Inc. Corporate Office | cGMP Deviations: Products were stored outside the drug label specifications. |
Source: FDA Enforcement Report (drug recalls) via openFDA, through October 8, 2026
What does the multiple vitamins label say about other medicines?
The multiple vitamins label names 17 other medicines in its interaction, contraindication or warning sections. The labels of 4 other medicines name multiple vitamins. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
| Medicine named | Section | What the label says |
|---|---|---|
| Ascorbic acid | drug interactions | Effect of INFUVITE PEDIATRIC on other drugs: Thiamine, riboflavin, pyridoxine, niacinamide, and ascorbic acid decrease activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin |
| Bleomycin | drug interactions | Ascorbic acid and riboflavin may reduce the activity of bleomycin |
| Chloramphenicol | drug interactions | Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited |
| Cyanocobalamin | warnings and precautions | Diagnosis of Megaloblastic Anemia INFUVITE PEDIATRIC contains folic acid and cyanocobalamin which can mask serum deficiencies of folic acid and cyanocobalamin in patients with megaloblastic anemia. |
| Doxycycline | drug interactions | Effect of INFUVITE PEDIATRIC on other drugs: Thiamine, riboflavin, pyridoxine, niacinamide, and ascorbic acid decrease activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin |
| Erythromycin | drug interactions | Effect of INFUVITE PEDIATRIC on other drugs: Thiamine, riboflavin, pyridoxine, niacinamide, and ascorbic acid decrease activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin |
| Hydralazine | drug interactions | Hydralazine, Isoniazid: Concomitant administration of hydralazine or isoniazid may increase pyridoxine requirements ( 7.2 ). |
| Isoniazid | drug interactions | Hydralazine, Isoniazid: Concomitant administration of hydralazine or isoniazid may increase pyridoxine requirements ( 7.2 ). |
| Levodopa | drug interactions | Pyridoxine may decrease blood levels of levodopa and levodopa efficacy may decrease |
| Lincomycin | drug interactions | Effect of INFUVITE PEDIATRIC on other drugs: Thiamine, riboflavin, pyridoxine, niacinamide, and ascorbic acid decrease activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin |
| Methotrexate | drug interactions | Methotrexate: Folic acid may decrease response to methotrexate ( 7.1 ) Effects of other drugs on INFUVITE PEDIATRIC: |
| Phenytoin | drug interactions | Folic acid may decrease phenytoin blood levels and increase risk of seizure activity |
| Pyridoxine | drug interactions | Effect of INFUVITE PEDIATRIC on other drugs: Thiamine, riboflavin, pyridoxine, niacinamide, and ascorbic acid decrease activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin |
| Streptomycin | drug interactions | Effect of INFUVITE PEDIATRIC on other drugs: Thiamine, riboflavin, pyridoxine, niacinamide, and ascorbic acid decrease activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin |
Every other medicine the multiple vitamins label names
| Medicine named | Section | What the label says |
|---|---|---|
| Thiamine | drug interactions | Effect of INFUVITE PEDIATRIC on other drugs: Thiamine, riboflavin, pyridoxine, niacinamide, and ascorbic acid decrease activities of erythromycin, kanamycin, streptomycin, doxycycline, and lincomycin |
| Vitamin a | warnings and precautions | Therefore, supplementation of renal failure patients and patients with liver disease with vitamin A, an ingredient found in INFUVITE PEDIATRIC, should be undertaken with caution [see Use in Specific … |
| Warfarin | drug interactions | In patients who are co-administered warfarin and INFUVITE PEDIATRIC, blood levels of prothrombin/INR should be monitored to determine if dose of warfarin needs to be adjusted [see Warnings and … |
Source: FDA drug label (Infuvite Pediatric), Sandoz Inc, effective November 20, 2024 (SPL set 6d06546e-8b0a-4490-82d9-397bd902a044), via openFDA; the full label on DailyMed
What do FAERS reports show for multiple vitamins?
The FDA Adverse Event Reporting System holds 156 reports that list multiple vitamins among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 2 are coded as a death and 9 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Multiple vitamins side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other